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Summary We demonstrated that four human oesophageal squamous cell carcinoma cell lines (TE8, TE9,
TEIO and TEl1) produced matrix metalloproteinase-I (proMMP-1/tissue collagenase), 2 (ProMMP-2/'type IV
collagenase'), 3 (proMMP-3/stromelysin), and 9 (proMMP-9/92-kDa gelatinase) as members of a matrix
metalloproteinase (MMP) family, which degrades extracellular matrix macromolecules. Under normal culture
conditions, in immunoblot analysis, proMMP-1 of M,= 53,00 was detected in one cell line (TE8), proMMP-2
of Mr = 72,000 in three cell lines (TE9, TE1O, and TEl 1), and proMMP-3 of M, = 57,000 in all four cell lines.
In addition to these enzymes, in enzymography, a gelatinolytic activity around M,= 92-kDa, likely to be
proMMP-9, was detected in only one cell line (TEIO) under normal culture conditions. When these cell lines
were treated with epidermal growth factor (EGF), however, the agent stimulated three cell lines (TE8, TEIO
and TEl 1) to produce proMMP-9 in a dose-dose dependent manner. Oesophageal carcinoma-conditioned
medium stimulated oesophageal fibroblasts to produce proMMP-1, -2, and -3, suggesting that the interaction
between oesophageal carcinoma and stromal fibroblasts also plays a role in the production of MMPs by the
latter.
Our present study illustrates that oesophageal squamous cell carcinoma produces a variety of MMPs
including proMMP-1, -2, -3, and -9 in vitro, suggesting that the ability of MMP production of the tumour may
play an important role in its malignant behaviour and that the production of proMMP-9 may be regulated by
EGF via overexpression of EGF receptors.
Destruction or penetration of the basement membrane is
thought to be an essential step in successful metastasis by
tumour cells (Goldberg et al., 1990; Liotta et al., 1986;
Murphy et al., 1989). Thus, enzymes that can degrade extra-
cellular matrix macromolecules, including basement memb-
rane components, are believed to play an important role in
the process of tumour invasion and metastasis. Recently,
many research groups have proposed that invasive tumour
cells secrete matrix-degrading proteinases, such as matrix
metalloproteinases (MMPs) (Liotta et al., 1986), plasminogen
activator (Dano et al., 1985; Niedabala & Sartorelli, 1989),
and cathespins (Sloane & Honn, 1984). In particular, the
MMP family, including MMP-1 (tissue collagenase [Welgus
et al., 1981]), MMP-2 (72-kDa gelatinase/'type IV colla-
genase' [Murphy et al., 1985; Okada et al., 1990]), and
MMP-3 (stromelysin [Okada et al., 1986]), is closely assoc-
iated with the process of tumour invasion and metastasis
(Irimura et al., 1987; Liotta, 1986; Monteagudo et al., 1990;
Reich et al., 1988). In our previous study (Shima et al.,
1992), we also found that MMPs play an important role in
the metastasis of oesophageal squamous cell carcinoma:
immunohistochemical examination demonstrated that the
expression of MMPs is correlated with tumour invasion and
lymph node metastasis of the oesophageal carcinoma.
Several studies have shown that the production of MMP-1
and -3 by mouse or human fibroblasts may be stimulated by
epidermal growth factor (EGF), platelet-derived growth fac-
tor (PDGF), transforming growth factor-a (TGF-x), and
tumour promoters such as 12-O-tetradecanoyl-phorbol-13-
acetate (TPA) (Chua et al., 1985; Kerr et al., 1988). We have
also reported that proMMP-1 production by vascular
smooth muscle cells or proMMP-3 production by stromal
cells of giant cell tumour of bone is stimulated by PGDF,
interleukin 1, and/or TPA (Sasaguri et al., 1992; Yanagi et
al., 1991). These findings strongly suggest that the production
of MMPs by oesophageal carcinoma may be regulated by
growth factors such as EGF and/or TGF-a and that the
expression of MMPs and EGF receptors may be closely
associated with the malignant potential of oesophageal car-
cinoma. In fact, overexpression of EGF receptors is a com-
mon property of oesophageal carcinoma (Kamata et al.,
1986; Yamamoto et al., 1986); and TGF-a as well as EGF
binds to the EGF receptor on the same cell surface, although
TGF-o is only half as efficient as EGF (Derynck et al., 1987).
In the present study, we first demonstrate the ability of
human oesophageal squamous carcinoma cell lines to pro-
duce MMPs and then examine the effects of EGF on MMP
production by these cell lines. We also discuss the role of
MMPs in the malignant potential of squamous cell car-
cinoma.
Materials and methods
Cell culture
Squamous carcinoma cell lines (TE8, TE9, TE1O and TEl 1)
derived from human oesophageal carcinomas (Akaishi, 1984;
Akaishi et al., 1988) were gifts from Dr T. Nishihira (The
Second Department of Surgery, Tohoku University, Sendai,
Japan). Oesophageal fibroblasts were isolated from oeso-
phageal tissues of patients with oesophageal carcinoma.
These cell lines were maintained in Dulbecco's modified
Eagle's medium (DMEM [Nissui Pharmaceutical Co., Tokyo])
containing 10% foetal bovine serum (FCS) supplemented
with 100 units ml-' of penicillin and 10 pg ml1' of strepto-
mycin (Gibco, Grand Island, NY) in humidified 5% Co2/
95% air at 37°C. Human oesophageal fibroblasts and mono-
cytic leukaemia U937 were incubated in serum-free medium
for 3 days, and then the fibroblast- or monocytic leukaemia
U937-conditioned medium was stocked at -70°C until used
in experiments.
Western blot analysis andgelatin-zymography
One millilitre of cell suspension at a concentration of 1 x 104
cellsml-' was introduced into each of several 35-mm Petri
dishes. After subconfluence had been reached, the old
medium was removed, and the culture washed three times
with phosphate-buffered saline (PBS); I ml of serum-free
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DMEM containing one of various concentrations of EGF
(Wako Pure Chem. Ind. Ltd., Osaka, Japan) was added to
each dish. After incubation for 3 days, the medium was
collected and used for Western blot analysis and gelatin-
zymography, as described previously (Morodomi et al., 1992;
Yanagi et al., 1991). The serum-free conditioned medium was
first subjected to sodium dodecylsulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) under reducing conditions and
then electrotransferred to a microcellulose filter (0.45 micron
pore size) at 200mA for 2 h at 4°C. Reconstituted non-fat
dried milk (20%, W/V) was used in the blocking step as
described previously (Sasaguri et al., 1991; Yanagi et al.,
1991). The filter was treated for 4h at room temperature
with sheep anti-(human proMMP-1) serum, rabbit anti-
(human proMMP-2) or sheep anti-(human proMMP-2)
serum, or sheep anti-(human MMP-3) serum, all gifts from
Dr H. Nagase (Okada et al., 1986, 1989; Sasaguri et al.,
1992, 1991; Yanagi et al., 1991). After extensive washing, the
filter was incubatd with alkaline phosphatase-conjugated rab-
bit anti-(sheep IgG) IgG or goat anti-(rabbit IgG) IgG for
4h at room temperature. Immunoreactivity of MMPs was
visualised with 5-bromo-4-chloro-3-indolyl phosphate di-
sodium salt (BCIP) and nitroblue tetrazolium chloride (NBT)
in carbobionate buffer. Prestained protein standards (Bio
Rad Lab., Richmond, CA) were used for the estimation of
Mr.
Gelatinolytic activity was determined by SDS-PAGE under
reducing conditions with a 10% polyacrylamide gel of 1-mm
thickness containing gelatin (0.8 mgml-') as described
previously (Morodomi et al., 1992; Sasaguri et al., 1992;
Yanagi et al., 1991). The serum-free conditioned medium,
untreated or treated with IlM-4-aminophenylmercuric ace-
tate (APMA), was mixed with SDS sample buffer; and after
electrophoresis, the gel was gently shaken in 50 mM Tris-HCI
buffer (pH 7.5)/5 mM Ca2+/1 ltM Zn2+/1% Triton X-100/
0.02% NaN2 for 3 days at room temperature. For visualisa-
tion of gelatinolytic activities, the gels were incubated in
0.02% Coomassie brilliant blue R-250 for 1 h. The activities
were detected as zones of negative staining with the dye.
Immunofluorescence ofMMPs in cultured cells
For immunofluorescence staining, oesophageal carcinoma
cells were seeded on Lab Tek chamber slides (Nunc, Inc,
Naperville, IL) and incubated with 1 jig ml - of monensin
(Sigma Chem. Co., St. Louis, MO) for 16 h prior to fixation
with cold 95% acetone for 1 min, as described previously
(Sasaguri et al., 1991). After incubation with oesophageal
carcinoma-conditioned medium for 2 days, oesophageal
fibroblasts were also tested by immunofluorescence staining.
They were dried by air and rehydrated with PBS. After
incubation with the first antibody for 1 h at room tempera-
ture, the specimens were washed with PBS followed by incu-
bation with fluorescent isothiocyanate (FITC)-conjugated
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rabbit anti-(sheep IgG) IgG or goat anti-(rabbit IgG) IgG for
1 h at room temperature. These specimens were finally over-
laid with glycerin and observed under an Olympus immuno-
flourescence microscope.
Results
Production ofMMPs by oesophageal squamous cell carcinoma
lines
Serum-free conditioned-medium from each cell line was
applied to immunoblot analysis. As shown in Figure 1, the
production of proMMP-2 of M, = 72,000 was detected in
TE9, TElO, and TEl (Figure lb); and that ofproMMP-3 of
Mr= 57,000, in all four carcinoma cell lines (Figure 1c),
whereas proMMP-1 ofMr= 53,000 was detected only in TE8
(Figure la).
Immunofluorescence microscopy demonstrated the pre-
sence of these enzymes in the cells (Figure 2). Although the
antibody against proMMP-2 shows slight cross-reactivity
with proMMP-9, as previously reported (Morodomi et al.,
1992), in this immunoblot examination no proMMP-9 band
was detected with any of the cell lines, suggesting that the
amount of proMMP-9 produced under normal culture condi-
tions is very little. Fluorescence of proMMP-1 was observed
in TE8 (Figure 2a), that of proMMP-2 in TE9 (Figure 2b),
TEIO, and TEl1, and that of proMMP-3 in all four cell lines
(Figure 2c) in parallel with the results of immunoblotting.
Gelatinolytic activities in conditioned-medium
To investigate gelatinolytic activity, we analysed serum-free
conditioned-medium from each cultured cell line by gelatin-
zymography (Figure 3). TE9 (Figure 3-2) expressed two
major gelatin-cleaving activities, which were attributed to
proMMP-3 of Mr = 57,000 and proMMP-2 of Mr = 72,000.
TE8 (Figure 3-1) and TEl1 (Figure 3-4) expressed minor a
gelatin-cleaving activity at Mr = 57,000 or two activities at
Mr = 57,000 and Mr= 72,000 respectively. TEIO (Figure 3-3)
expressed one major gelatin-cleaving activity of Mr= 57,000
corresponding to proMMP-3, and two additional minor gela-
tin-cleaving activities at M, = 72,000 and Mr = 92,000, which
corresponded to proMMP-2 and proMMP-9, respectively.
These data are also in parallel with the results of immuno-
blotting except for proMMP-9.
Effect ofEGFon theproduction ofMMPs
To investigate the effect of EGF on MMP production by
these cell lines, we analysed the conditioned media by gelatin-
zymography after the cell lines had been incubated with
various concentrations of EGF for 3 days. EGF markedly
stimulated TEIO to produce proMMP-9, while the effect of
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Figure 1 Secretion of proMMP-1, -2 and -3 by oesophageal squamous cell carcinoma cell lines. Twenty microlitres of serum-free
conditioned medium from each cell line was loaded onto an SDS-PAGE gel. Immunoblot analysis demonstrates that TE8 (lane 1)
secreted proMMP-l of Mr= 53,000 a; TE9 (lane 2), TE0 (lane 3), and TE 11 (lane 4), proMMP-2 of Mr = 72,000 b; and all cell
lines, proMMP-3 of M, = 57,000 c. Variations in band intensity indicate different levels of production of proMMP-2 and -3 by the
carcinoma cell lines producing them.MATRIX METALLOPROTEINASE 9 IN OESOPHAGEAL CANCER
Figure 2 Detection of proMMP production in oesophageal squamous cell carcinoma cell lines. Immunofluorescence staining
shows the production of proMMP-1 (a, TE8), -2 (b, TElO) and -3 (c, TE8) by these cells. Brightness of immunofluorescence
observed in each cell line is in parallel with immunoblot band intensity.
the growth factor on the production of proMMP-2 and -3 by
this line was negligible (Figure 4b). Moreover, EGF also
slightly stimulated TE8 and TE 11 to increase the gelatinolytic
activity of MMP-9 (Figure 4a and c), whereas its activity in
these two cell lines was undetectable in the absence of the
growth factor. TE9 was unaffected by EGF in terms of
gelatinolytic activity.
In our previous paper (Morodomi et al., 1992), we re-
ported the characterisation of matrix metalloproteinase 9
from U937 monocytic leukaemia. The major gelatinolytic
activity from TEIO was similar to that from U937 (Figure 5).
After activation with 1 tLM APMA, proMMP-9 of molecular
mass of 92-kDa from TEIO was converted into 82-kDa and
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70-kDa forms (Figure 5a), indicating that the major band
from TEIO is identical with proMMP-9 from U937 (Figure
Sb).
Effect ofoesophageal carcinoma-conditioned medium on
proMMP-J, -2 and -3
Oesophageal fibroblasts were incubated with oesophageal
carcinoma-conditioned medium for 2 days, and the produc-
tion of proMMP-1, -2, and -3 in the cells was tested by
antibodies against these enzymes.
Immunoflourescence staining showed that the oesophageal
carcinoma-conditioned medium from TE9 stimulated fibro-
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Figure 3 Detection of gelatinolytic activity in conditioned medium by gelatin-zymography. Zymography shows gelatinolytic
activities in each sample. TE8 (lane 1) shows an activity at M,= 57,000 (proMMP-3); TE9 (lane 2) gives major and minor bands,
at M, = 72,000 and M,= 57,000, respectively; and TElO (lane 3) shows a major band at M, = 57,000 and two minor bands at
M, = 72,000 and M, = 92,000 (proMMP-9); and TE Il (lane 4) gives two bands, at M, = 72,000 and M, = 57,000.
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1 2 3 4 5 a amount of a given MMP produced varied with the cell line,
indicating differences among the squamous cell carcinoma
92k cell lines in their ability to produce the same MMP. We
therefore considered that such differences might be present in
oesophageal carcinomas in vivo too. That would suggest that
57k malignant potential may vary among individual squamous
cell carcinomas. These data and our reasoning, if correct,
would strongly indicate that the analysis of MMP expression
in tissue is useful for evaluation of the metastatic potential in
individual squamous cell carcinomas, as described previously
(Shima et al., 1992).
Non-neoplastic normal cell, such as fibroblasts (Collier et
al., 1988), vascular smooth muscle cells (Yanagi et al., 1991),
and endothelial cells (Kalebic et al., 1983) have been reported
to secrete proMMP-l, -2, and/or -3, which can degrade type
2 3 4 5 b I, II, III, IV, and V collagens, laminin, gelatin (denatured
collagen), fibronectin and proteoglycan. Furthermore, several
92k investigators have described a gelatinolytic enzyme of high
72k molecular weight (M, = 90,000-92,000) produced by neutro-
phils (Uitto et al., 1980) or macrophages (Garbisa et al.,
57k 1986), indicating that the ability to produce such enzymes
may be one of the key requirements for these inflammatory
cells to migrate from peripheral blood to the inflammatory
site. It was also reported that proMMP-9 is secreted by
transformed cell lines originating from fibroblasts (Wilhelm
et al., 1989) and by several tumour cells (Ballin et al., 1988;
Yamagata et al., 1988). In a previous study (Morodomi et
al., 1992), we reported that activated MMP-9 from U937
monocytic leukaemia and HT1080 fibrosarcoma digests gela-
tin, collagen type V, reduced-carboxymethylated transferrin,
2 3 4 5 c type IV collagen, and laminin A chain. In the present study,
upon zymography, we also found that the production of the
92k enzyme of M, = 92,000 was demonstrable in three cell lines.
These results on zymography indicated that the enzyme of
. ~~~~Mr =92,000 was identical to proMMP-9 from U937. Since
_ _ i unlike proMMP-1, -2 and/or -3, detectable amounts of _-l57k proMMP-9 are not produced by normal cells such as fibro-
blasts, we consider the production of proMMP-9 to be one
of the most important factors for migration of tumour cells
into the bloodstream or lymphatic vessels, or into adjacent
normal tissues. It stands to reason that proMMP-9-mediated
enzymatic degradation of type IV collagen and laminin,
which are the most important basement membrane compon-
ents, has been implicated in invasive and metastatic growth
(Ballin et al., 1988; Lyons et al., 1991).
The results from immunofluorescence staining of oesopha-
ct of EGF on produciton of MMPs by oesophageal geal fibroblasts, which had been cultured in oesophageal
carcinoma lines. Except for TE9, EGF markedly carcinoma-conditioned medium, suggested that oesophageal
a, TEIO b, and TEll c to produce proMMP-9 of carcinoma cell produced some factor(s) that stimulates
vhile the growth factor fails to augment the prod- stromal fibroblasts to secrete proMMP-1, -2 and -3. In our
MMP n1 -2 and -3 by any of the cell lines. 1, previous paper (Shima et al., 1992), we observed by immuno- 1ngml', 3, lOng ml ; 4, 50Engml-'; 5 histochemical staining that the amount ofproMMP-l, -2 and
*
EGF. -3 produced by carcinoma cells in tissues was larger than that
by stromal fibroblasts. We also considered, however, that the
interaction between oesophageal carcinoma and stromal
fibroblasts plays a role in the production of MMPs by the
ace proMMP-2 and -3 (Figure 6) and that to a latter.
-he conditioned medium from TE8, TEIO, and In the present study, EGF stimulated squamous cell car-
rhtly stimulated the production of proMMP-l cinoma cell lines to produce proMMP-9, but not proMMP-l,
ymography, the stimulation of production of -2 and -3. Interestingly, it has been reported that squamous
fibroblasts was not detected. carcinoma cell display overexpression of EGF receptors (Ka-
mata et al., 1986; Yamamoto et al., 1986; Ozawa et al.,
1987). These studies suggest that EGF and its receptors are
one of the regulatory factors for the production ofproMMP-9.
Ozawa et al. (1987) and Ozanne et al. (1986) further reported
we have demonstrated by immunoblotting and that the growth of squamous cell carcinoma was promoted
cence analyses that human oesophageal car- by EGF in proportion to the number of EGF receptors per
ies can secrete at least three kinds of MMPs, cell. In addition, Yano et al. (1991) reported, based on
proMMP-l of M, = 53,000, proMMP-2 of immunohistochemical observations, that oesophageal
Lnd proMMP-3 of M,= 57,000. These results, squamous cell carcinomas with extensively expressed EGF
atained with specific antibodies against human receptors would have a far poorer prognosis and would
tlly agree with previous studies where different metastasise to lymph nodes more frequently than those
gnant tumours were shown to produce large whose EGF receptors were expressed to a lesser extent. That
atrix-degrading enzymes associated with their means that EGF stimulation mediated by its own receptors is
iaviour. Our results also revealed that the one of the most important requirements for fully malignantMATRIX METALLOPROTEINASE 9 IN OESOPHAGEAL CANCER 725
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Figure 5 Comparison between squamous cell carcinoma- and U937-conditioned medium for their production of the enzyme of
Mr = 92,000. On zymography under reducing conditions, TEIO (al) and U937 (bl) produce a enzyme of M, = 92,000. Upon
activation with 1 JAM APMA, both molecular masses 92-kDa are converted into the 84-kDa the 82-kDa and the 70-kDa forms (a2,
TEIO and b2, U937).
behaviour of squamous cell carcinoma. Indeed, in the present
study, we demonstrated that one cell line (TE10) can secrete
proMMP-9 under normal culture conditions and that EGF
stimulates an additional two cell lines (TE8 and TEl1) to
produce proMMP-9 in a dose-dependent manner.
It remains unknown, however, what specific mechanisms
regulate the production of MMPs in oesophageal carcin-
omas. Kerr et al. (1988) have described that proMMP-3 gene
expression is regulated by PDGF in a c-fos-dependent man-
ner and by EGF in a manner independent of c-fos and that
the stimulatory effect of both PDGF and EGF on proMMP-3
transcription involves factors that recognise the promoting
region (AP-1 site), which they reported to be a binding site
for the transcriptional factor Jun/Fos complex. It is known
that the increasing binding of the transcriptional factor to the
AP-1 site of proMMP-1, -3 and -9 genes results in an in-
crease in transcription of these genes (Angel et al., 1987;
Huhtalal et al., 1991), whereas the MMP-2 gene does not
contain the AP-1 binding region in its upstream (Huhtala et
al., 1990). Our previous study (Sasaguri et al., 1992) has
described that the production of proMMP-2 and -3 by giant
cell tumour of bone was stimulated by cytokines, whereas the
Figure 6 Immunofluoresence assay for the effect of squamous cell carcinoma-conditioned medium from TE9 on the production of
proMMP-2 and -3 by oesophageal fibroblasts. The squamous cell carcinoma-conditioned media from TE9 stimulate oesophageal
fibroblasts to produce proMMP-2 (b and e) and -3 (c and f), but fails to stimulate the production of proMMP-l (a and d) by them.
a, b, and c: serum-free DMEM; c, d and f: serum-free DMEM containing 50% oesophageal carcinoma-conditioned medium.
Bar= 10lgm.
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production of proMMP-l by the tumour was not detected.
Furthermore, unlike proMMP-1 and -3, proMMP-9 is
physiological secreted by neutrophils and macrophages to aid
in their migration from blood into tissue, but not by other
normal cells such as normal fibroblasts. The above data
strongly indicate that the mechanism of regulation of the
production of MMPs differ according to the proteinase and
the cell type that is involved.
In conclusion, we have shown that oesophageal carcinoma
cells may be stimulated by EGF to produce large amounts of
proMMP-9, the production of which is mediated by over-
expressed EGF receptors, and which results in pronounced
destruction of stromal tissue. Thus, we conclude that MMP
production or EGF-EGF receptor-stimulated proMMP-9
production by oesophageal carcinoma, in particular, may
play an important role in the invasion and metastasis of such
cancers and that the analysis of MMP expression in tissues is
useful for evaluation of the metastatic potential of individual
squamous cell carcinomas.
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